— Ticker · NYQ —

ELV · Elevance Health, Inc.

Healthcare · Healthcare Plans

Elevance Health, Inc.

NYQ · Healthcare / Healthcare Plans
All sectors →
ELV
$421.86
▲ +2.15%
7-day move
day$418.99 → $422.9952-wk$274.84 → $436.24avg vol1.3M / 3Mcap$91.5B
Plate I.

The Past Year, in One Line

$380$400$420$440$460202120222023202420252026$421.86ELV
The Valuation
P/E (forward)14.2
P/E (trailing)18.7
EPS (forward)$29.61
EPS (trailing)$22.61
PEG1.37
Dividend1.62%
The Risk
Beta0.70
Short % float2.83%
Float216.4M
Shares out216.9M
Avg vol (3M)1.3M
52w range$274.84 → $436.24
The Analyst Tape
strong buybuyholdunderperformsell
$450.05
avg 12-mo target
+6.7%
vs. last · 21 analysts
At a Glance
$91.5B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryHealthcare Plans
market cap$91.5B
websiteelevancehealth.com

The Briefs

live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for ELV in the last 7 days.

Word on the Street

StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for ELV.

Indicators That Mention ELV

8 of our 658 catalog map to ELV
SP-1251
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-3079
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
●Still works on fresh data
r=-0.03
SP-1365
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.02
SP-1458
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
●Still works on fresh data
r=-0.04
SP-3601
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3174
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
○Not yet retested on fresh data
r=0.00
SP-3646
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3667
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 658 indicators against six horizons. By chance alone, ~197 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.

Other Players in the Pipeline

Healthcare · by market cap · 7-day move
Metadata last refreshed 2026-09-15T13:57:51.546219+00:00 via yfinance. Price figures are end-of-day; intraday quotes are not surfaced on the free tier. We don't provide investment advice — see methodology for what we do and don't claim.

— Voices on ELV —commentarylive

Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning ELV. Opinion, not wire.
No recent commentary mentioning ELV in the last 7 days.
Analyst · previewYou're seeing the public read on ELV. Analyst unlocks every pundit call on ELV with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with ELV as the target + the API / MCP feed.Compare tiers →